RaQualia Pharma Balance Sheet Health
Financial Health criteria checks 3/6
RaQualia Pharma has a total shareholder equity of ¥6.1B and total debt of ¥51.0M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are ¥6.9B and ¥752.0M respectively.
Key information
0.8%
Debt to equity ratio
JP¥51.00m
Debt
Interest coverage ratio | n/a |
Cash | JP¥3.76b |
Equity | JP¥6.12b |
Total liabilities | JP¥752.00m |
Total assets | JP¥6.87b |
Financial Position Analysis
Short Term Liabilities: 4579's short term assets (¥5.0B) exceed its short term liabilities (¥389.0M).
Long Term Liabilities: 4579's short term assets (¥5.0B) exceed its long term liabilities (¥363.0M).
Debt to Equity History and Analysis
Debt Level: 4579 has more cash than its total debt.
Reducing Debt: 4579's debt to equity ratio has increased from 0% to 0.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 4579 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 4579 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.